Trials / Completed
CompletedNCT04768400
MEP and Neuromuscular Blocker
Quantitative Analysis Between Neuromuscular Blocking Agent and Motor Evoked Potential and Analysis of Risk Factors for the Coefficient of Variance of Motor Evoked Potential in Patients Undergoing Brain Tumor Removal Surgery: Population Approach
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Gangnam Severance Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
It is important to predict the influence of the neuromuscular blocking agents on the motor evoked potential. Investigator will investigate the dose-response relationship between the degree of the neuromuscular blockade and the motor evoked potential in patients undergoing brain tumor surgery using the population approach. Investigator will investigate the influence of the other factors such as the impedence, reactance, muscel amount, and age on the motor evoked potential.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Arm I (MEP) | Arm I (MEP): Motor evoked potential will be measured in various degree of the neuromuscular blockade. |
Timeline
- Start date
- 2021-03-09
- Primary completion
- 2022-05-13
- Completion
- 2022-05-13
- First posted
- 2021-02-24
- Last updated
- 2023-06-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04768400. Inclusion in this directory is not an endorsement.